Joinn Laboratories (China) Co.,Ltd. Stock OTC Markets
Stocks
JNNL.Y
US47972L1089
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 31.57B 4.7B 4.13B 3.9B 3.56B 6.65B 451B 6.7B 46.77B 18.13B 230B 17.65B 17.27B 747B | P/E 2026 * |
38.2x | P/E 2027 * | 57.9x |
|---|---|---|---|---|---|
| Enterprise Value | 29.69B 4.42B 3.89B 3.66B 3.34B 6.25B 424B 6.3B 43.98B 17.04B 216B 16.6B 16.23B 703B | EV / Sales 2026 * |
16x | EV / Sales 2027 * | 13.9x |
| Free-Float |
64.87% | Yield 2026 * |
0.73% | Yield 2027 * | 0.36% |
| Manager | Title | Age | Since |
|---|---|---|---|
Da Peng Gao
CEO | Chief Executive Officer | 44 | 28/01/2019 |
Ai Shui Yu
DFI | Director of Finance/CFO | 50 | 10/04/2020 |
Jing Liang Gu
PRN | Corporate Officer/Principal | 46 | 23/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Yu Xia Feng
CHM | Chairman | 62 | 11/08/1995 |
Da Peng Gao
BRD | Director/Board Member | 44 | 10/12/2012 |
Ye Li
CHM | Chairman | 44 | 10/12/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 4.7B | |
| -1.25% | +3.19% | +8.69% | +30.29% | 48.01B | |
| +2.67% | +2.07% | +51.74% | +38.37% | 45.27B | |
| -1.38% | +1.84% | +9.13% | +88.88% | 40.93B | |
| +4.78% | +1.48% | +359.03% | +566.20% | 42.84B | |
| -0.62% | -1.61% | +5.30% | +46.02% | 29.6B | |
| +0.56% | +0.88% | +24.79% | +155.71% | 17.32B | |
| -0.67% | +0.97% | +26.48% | +40.99% | 15.34B | |
| +3.39% | -3.49% | - | - | 15.15B | |
| +7.38% | +2.34% | +3.80% | - | 14.84B | |
| Average | +0.21% | +1.02% | +61.12% | +138.07% | 29.92B | |
| Weighted average by Cap. | +0.03% | +1.56% | +76.97% | +149.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.85B 275M 242M 228M 208M 390M 26.44B 393M 2.74B 1.06B 13.45B 1.03B 1.01B 43.78B | 2.12B 315M 277M 261M 238M 446M 30.25B 449M 3.14B 1.22B 15.4B 1.18B 1.16B 50.1B |
| Net income | 767M 114M 100M 94.69M 86.39M 162M 10.96B 163M 1.14B 440M 5.58B 429M 419M 18.16B | 381M 56.72M 49.89M 47.03M 42.91M 80.24M 5.44B 80.87M 564M 219M 2.77B 213M 208M 9.02B |
| Net Debt | -1.89B -281M -247M -233M -212M -397M -26.95B -400M -2.79B -1.08B -13.72B -1.05B -1.03B -44.63B | -2.12B -316M -278M -262M -239M -447M -30.33B -450M -3.14B -1.22B -15.43B -1.19B -1.16B -50.23B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
